- Type / Class
- Equity / Common Stock
- Shares outstanding
- 129,668,560
- Total 13F shares
- 112,517,309
- Share change
- +396,793
- Total reported value
- $1,039,664,895
- Put/Call ratio
- 24%
- Price per share
- $9.24
- Number of holders
- 235
- Value change
- +$6,813,825
- Number of buys
- 114
- Number of sells
- 101
Quarterly Holders Quick Answers
What is CUSIP 64049M209?
CUSIP 64049M209 identifies NEO - NEOGENOMICS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 64049M209:
Top shareholders of NEO - NEOGENOMICS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
16%
|
21,109,182
|
$181,750,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
13,174,708
|
$113,434,000 | — | 30 Sep 2022 | |
| BROWN ADVISORY INC |
13F
|
Company |
4.8%
|
6,180,735
|
$53,215,000 | — | 30 Sep 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
4.6%
|
5,961,144
|
$51,329,000 | — | 30 Sep 2022 | |
| Douglas M. van Oort |
3/4/5
|
Director |
—
mixed-class rows
|
2,708,881
mixed-class rows
|
$45,677,027 | — | 01 Aug 2021 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
4,217,160
|
$36,310,000 | — | 30 Sep 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
2.5%
|
3,208,459
|
$27,625,000 | — | 30 Sep 2022 | |
| First Light Asset Management, LLC |
13F
|
Company |
2.1%
|
2,720,099
|
$23,420,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
2,649,916
|
$22,816,000 | — | 30 Sep 2022 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2%
|
2,568,909
|
$22,119,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
2,349,513
|
$20,229,000 | — | 30 Sep 2022 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
1.7%
|
2,139,579
|
$18,422,000 | — | 30 Sep 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.6%
|
2,073,414
|
$17,852,000 | — | 30 Sep 2022 | |
| Greenhouse Funds LLLP |
13F
|
Company |
1.6%
|
2,009,868
|
$17,305,000 | — | 30 Sep 2022 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.5%
|
1,918,276
|
$16,524,000 | — | 30 Sep 2022 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
1.3%
|
1,727,572
|
$14,874,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
1,641,073
|
$14,130,000 | — | 30 Sep 2022 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,633,904
|
$14,067,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
1,544,640
|
$13,299,000 | — | 30 Sep 2022 | |
| Kopp Family Office, LLC |
13F
|
Company |
1.2%
|
1,539,113
|
$13,252,000 | — | 30 Sep 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.1%
|
1,401,601
|
$12,068,000 | — | 30 Sep 2022 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
1,316,291
|
$11,333,000 | — | 30 Sep 2022 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.97%
|
1,257,286
|
$10,824,000 | — | 30 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.96%
|
1,247,715
|
$10,744,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.95%
|
1,226,483
|
$10,560,000 | — | 30 Sep 2022 | |
| NORGES BANK |
13F
|
Company |
0.91%
|
1,186,214
|
$10,213,303 | — | 30 Sep 2022 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.86%
|
1,111,874
|
$9,576,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.85%
|
1,103,571
|
$9,501,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.82%
|
1,067,207
|
$9,189,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.8%
|
1,042,700
|
$8,978,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.75%
|
973,871
|
$8,385,000 | — | 30 Sep 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
945,830
|
$8,144,000 | — | 30 Sep 2022 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.61%
|
788,854
|
$6,792,000 | — | 30 Sep 2022 | |
| Mark Mallon |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
715,828
mixed-class rows
|
$6,768,458 | — | 01 Mar 2022 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.59%
|
768,186
|
$6,614,000 | — | 30 Sep 2022 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.59%
|
766,750
|
$6,602,000 | — | 30 Sep 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.56%
|
727,588
|
$6,266,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.52%
|
677,199
|
$5,831,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.52%
|
674,637
|
$5,809,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.51%
|
665,456
|
$5,730,000 | — | 30 Sep 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
663,882
|
$5,716,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.49%
|
633,201
|
$5,452,000 | — | 30 Sep 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.44%
|
565,860
|
$4,872,000 | — | 30 Sep 2022 | |
| George Cardoza |
3/4/5
|
President & COO, Lab Ops |
—
mixed-class rows
|
304,659
mixed-class rows
|
$4,857,847 | — | 01 Mar 2022 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.43%
|
552,469
|
$4,757,000 | — | 30 Sep 2022 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.32%
|
410,828
|
$3,537,000 | — | 30 Sep 2022 | |
| William Bonello |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
191,548
|
$3,522,568 | — | 28 Apr 2022 | |
| HealthCor Management, L.P. |
13F
|
Company |
0.3%
|
391,110
|
$3,367,000 | — | 30 Sep 2022 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.29%
|
377,967
|
$3,254,297 | — | 30 Sep 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.29%
|
376,148
|
$3,239,000 | — | 30 Sep 2022 |
Institutional Holders of NEOGENOMICS INC - Common Stock (NEO) as of Q4 2022
As of 31 Dec 2022,
NEOGENOMICS INC - Common Stock (NEO) was held by
235 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,517,309 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, BROWN ADVISORY INC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, T. Rowe Price Investment Management, Inc., Greenhouse Funds LLLP, GOLDMAN SACHS GROUP INC, First Light Asset Management, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
235
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
236
Q4 2022 holders
235
Holder diff
-1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.